ATR and neoplasm: Andersson et al.12 observed a dose dependent decrease in proliferation and increase in apoptosis following inhibition of ATR, a gene involved in DNA damage repair, and in vivo experimentation demonstrated significant tumor suppression and, in one case, tumor regression, supporting the development of therapeutic targets to ATR in the treatment of C-AdCC and possibly a subset of SB-AdCC.